Adenoviruses Types, Cell Receptors and Local Innate Cytokines in Adenovirus Infection

REFERENCES

• Tabain I, Ljubin-Sternak S, Cepin-Bogovic J, Adenovirus respiratory infections in hospitalized children: clinical findings in relation to species and serotypes. Pediatr Infect Dis J 2012;31(7):680–684.
   PubMedGoogle Scholar
• Thaci B, Ulasov IV, Wainwright DA, Lesniak MS. The challenge for gene therapy: innate immune response to adenoviruses. Oncotarget 2011;2(3):113–121.
   PubMedGoogle Scholar
• Sdiri-Loulizi K, Gharbi-Khelifi H, de Rougemont A, Molecular epidemiology of human astrovirus and adenovirus serotypes 40/41 strains related to acute diarrhea in Tunisian children. J Med Virol 2009;81(11):1895–1902.
   PubMedGoogle Scholar
• Moro MR, Bonville CA, Suryadevara M, Clinical features, adenovirus types, and local production of inflammatory mediators in adenovirus infections. Pediatr Infect Dis J 2009;28(5):376–380.
   PubMed Web of Science ®Google Scholar
• Greber UF, Arnberg N, Wadell G, Adenoviruses –from pathogens to therapeutics: a report on the 10th International Adenovirus Meeting. Cell Microbiol 2013;15(1):16–23.
   PubMedGoogle Scholar
• Harrison SC. Virology. Looking inside adenovirus. Science 2010;329(5995):1026–1027.
   PubMedGoogle Scholar
• Ferreon JC, Martinez-Yamout MA, Dyson HJ, Wright PE. Structural basis for subversion of cellular control mechanisms by the adenoviral E1A oncoprotein. Proc Natl Acad Sci USA 2009 Aug 11;106(32):13260–13265; Soria C, Estermann FE, Espantman KC, O'Shea CC. Heterochromatin silencing of p53 target genes by a small viral protein. Nature 2010;466(7310):1076–1081.
   PubMedGoogle Scholar
• Fechner H, Haack A, Wang H, Expression of coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers. Gene Ther 1999;6(9):1520–1535.
   PubMedGoogle Scholar
• Sirena D, Lilienfeld B, Eisenhut M, The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3. J Virol 2004;78(9):4454–4462; Gaggar A, Shayakhmetov DM, Lieber A. CD46 is a cellular receptor for group B adenoviruses. Nat Med 2003;9(11):1408–1412; Segerman A, Atkinson JP, Marttila M, et al. Adenovirus type 11 uses CD46 as a cellular receptor. J Virol 2003;77(17):9183–9191; Wu E, Trauger SA, Pache L, et al. Membrane cofactor protein is a receptor for adenoviruses associated with epidemic keratoconjunctivitis. J Virol 2004;78(8):3897–3905.
   PubMed Web of Science ®Google Scholar
• Riley-Vargas RC, Gill DB, Kemper C, CD46: expanding beyond complement regulation. Trends Immunol 2004;25(9):496–503.
   PubMedGoogle Scholar
• Wolfrum N, Greber UF. Adenovirus signalling in entry. Cell Microbiol 2013;15(1):53–62.
   PubMed Web of Science ®Google Scholar
• Gustafsson DJ, Andersson EK, Hu YL, Adenovirus 11p downregulates CD46 early in infection. Virology 2010;405(2):474–482.
   PubMedGoogle Scholar
• Wang H, Li ZY, Liu Y, Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14. Nat Med 2011;17(1):96–104.
   PubMed Web of Science ®Google Scholar
• Trinh HV, Lesage G, Chennamparampil V, Avidity binding of human adenovirus serotypes 3 and 7 to the membrane cofactor CD46 triggers infection. J Virol. 2012;86(3):1623–1637.
   PubMedGoogle Scholar
• Cashman SM, Morris DJ, Kumar-Singh R. Adenovirus type 5 pseudotyped with adenovirus type 37 fiber uses sialic acid as a cellular receptor. Virology 2004;324(1):129–139.
   PubMedGoogle Scholar
• Nilsson EC, Storm RJ, Bauer J, The GD1a glycan is a cellular receptor for adenoviruses causing epidemic keratoconjunctivitis. Nat Med 2011;17(1):105–109.
   PubMed Web of Science ®Google Scholar
• Dalrymple N, Mackow ER. Productive dengue virus infection of human endothelial cells is directed by heparan sulfate-containing proteoglycan receptors. J Virol 2011;85(18):9478–9485; Hallak LK, Spillmann D, Collins PL, Peeples ME. Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection. J Virol 2000;74(22):10508–10513; Hilgard P, Stockert R. Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes. Hepatology 2000;32(5):1069–1077; Tuve S, Wang H, Jacobs JD, et al. Role of cellular heparan sulfate proteoglycans in infection of human adenovirus serotype 3 and 35. PLoS Pathog 2008;4(10):e1000189.
   PubMed Web of Science ®Google Scholar
• Gout E, Schoehn G, Fenel D, The adenovirus type 3 dodecahedron's RGD loop comprises an HSPG binding site that influences integrin binding. J Biomed Biotechnol 2010;2010:541939.
   PubMedGoogle Scholar
• Kalin S, Amstutz B, Gastaldelli M, Macropinocytotic uptake and infection of human epithelial cells with species B2 adenovirus type 35. J Virol 2010;84(10):5336–5350.
   PubMedGoogle Scholar
• Wu E, Nemerow GR. Virus yoga: the role of flexibility in virus host cell recognition. Trends Microbiol 2004;12(4):162–169.
   PubMedGoogle Scholar
• Meier O, Greber UF. Adenovirus endocytosis. J Gene Med 2003;5(6):451–462.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Bergelson JM. Adenovirus receptors. J Virol 2005;79(19):12125–12131.
   PubMed Web of Science ®Google Scholar
• Heim A. Advances in the management of disseminated adenovirus disease in stem cell transplant recipients: impact of adenovirus load (DNAemia) testing. Expert Rev Anti Infect Ther 2011;9(11): 943–945.
   PubMed Web of Science ®Google Scholar
• Claas EC, Schilham MW, de Brouwer CS, Internally controlled real-time PCR monitoring of adenovirus DNA load in serum or plasma of transplant recipients. J Clin Microbiol 2005;43(4):1738–1744.
   PubMedGoogle Scholar
• Ganzenmueller T, Buchholz S, Harste G, High lethality of human adenovirus disease in adult allogeneic stem cell transplant recipients with high adenoviral blood load. J Clin Virol 2011;52(1): 55–59; Erard V, Huang ML, Ferrenberg J, et al. Quantitative real-time polymerase chain reaction for detection of adenovirus after T cell-replete hematopoietic cell transplantation: viral load as a marker for invasive disease. Clin Infect Dis 2007;45(8):958–965.
   PubMed Web of Science ®Google Scholar
• Teigler JE, Iampietro MJ, Barouch DH. Vaccination with adenovirus serotypes 35, 26, and 48 elicits higher levels of innate cytokine responses than adenovirus serotype 5 in rhesus monkeys. J Virol 2012;86(18):9590–9598.
   PubMed Web of Science ®Google Scholar
• Zsengeller Z, Otake K, Hossain SA, Internalization of adenovirus by alveolar macrophages initiates early proinflammatory signaling during acute respiratory tract infection. J Virol 2000;74(20): 9655–9667.
   PubMedGoogle Scholar
• Diaz PV, Calhoun WJ, Hinton KL, Differential effects of respiratory syncytial virus and adenovirus on mononuclear cell cytokine responses. Am J Respir Crit Care Med 1999;160(4):1157–1164.
   PubMedGoogle Scholar
• Nazir SA, Metcalf JP. Innate immune response to adenovirus. J Investig Med 2005;53(6):292–304.
   PubMedGoogle Scholar
• Zhang P, Summer WR, Bagby GJ, Nelson S. Innate immunity and pulmonary host defense. Immunol Rev 2000;173:39–51.
   PubMed Web of Science ®Google Scholar
• Pitkaranta A, Hovi T. Induction of interferon in human leukocyte cultures by natural pathogenic respiratory viruses. J Interferon Res 1993;13(6):423–426.
   PubMedGoogle Scholar
• Weber F, Wagner V, Kessler N, Haller O. Induction of interferon synthesis by the PKR-inhibitory VA RNAs of adenoviruses. J Interferon Cytokine Res 2006;26(1):1–7.
   PubMedGoogle Scholar
• Schaack J. Induction and inhibition of innate inflammatory responses by adenovirus early region proteins. Viral Immunol 2005;18(1):79–88.
   PubMedGoogle Scholar
• Pahl JH, Verhoeven DH, Kwappenberg KM, Adenovirus type 35, but not type 5, stimulates NK cell activation via plasmacytoid dendritic cells and TLR9 signaling. Mol Immunol 2012;51(1):91–100.
   PubMedGoogle Scholar
• Leopold PL, Wendland RL, Vincent T, Crystal RG. Neutralized adenovirus-immune complexes can mediate effective gene transfer via an Fc receptor-dependent infection pathway. J Virol 2006;80(20): 10237–10247.
   PubMedGoogle Scholar
• Timpe JM, Verrill KC, Trempe JP. Effects of adeno-associated virus on adenovirus replication and gene expression during coinfection. J Virol 2006;80(16):7807–7815.
   PubMedGoogle Scholar
• Tullis GE, Shenk T. Efficient replication of adeno-associated virus type 2 vectors: a cis-acting element outside of the terminal repeats and a minimal size. J Virol 2000;74(24):11511–11521.
   PubMedGoogle Scholar
• Manno CS, Chew AJ, Hutchison S, AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood 2003;101(8):2963–2972.
   PubMed Web of Science ®Google Scholar
• Bartlett JS, Samulski RJ, McCown TJ. Selective and rapid uptake of adeno-associated virus type 2 in brain. Hum Gene Ther 1998;9(8):1181–1186.
   PubMed Web of Science ®Google Scholar
• Richter M, Iwata A, Nyhuis J, Adeno-associated virus vector transduction of vascular smooth muscle cells in vivo. Physiol Genomics 2000;2(3):117–127.
   PubMedGoogle Scholar
• Koeberl DD, Alexander IE, Halbert CL, Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors. Proc Natl Acad Sci USA 1997;94(4):1426–1431.
   PubMedGoogle Scholar
• Surosky RT, Urabe M, Godwin SG, Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome. J Virol 1997;71(10):7951–7959.
   PubMed Web of Science ®Google Scholar
• Zaiss AK, Liu Q, Bowen GP, Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors. J Virol 2002;76(9):4580–4590.
   PubMedGoogle Scholar
• Chirmule N, Propert K, Magosin S, Immune responses to adenovirus and adeno-associated virus in humans. Gene Ther. 1999;6(9):1574–1583.
   PubMed Web of Science ®Google Scholar
• Sun JY, Anand-Jawa V, Chatterjee S, Wong KK. Immune responses to adeno-associated virus and its recombinant vectors. Gene Ther 2003;10(11):964–976.
   PubMed Web of Science ®Google Scholar
• Jooss K, Chirmule N. Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy. Gene Ther 2003;10(11):955–963.
   PubMed Web of Science ®Google Scholar